Evaluate the Efficacy and Safety of Brightening Micro-needle Patch on Facial Solar Lentigines
- Conditions
- Solar Lentigines
- Interventions
- Other: AIVÍA, Ultra-Brightening Spot Micro-needle PatchOther: Placebo Micro-needle Patch
- First Posted Date
- 2020-10-12
- Last Posted Date
- 2022-05-24
- Lead Sponsor
- Panion & BF Biotech Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT04583852
- Locations
- 🇨🇳
Department of Dermatology, National Taiwan University, Taipei, Taiwan
PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD
- Conditions
- Anemia of Chronic Kidney Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-09-10
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Panion & BF Biotech Inc.
- Target Recruit Count
- 141
- Registration Number
- NCT04543812
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
🇨🇳Taipei Medical University Hospital, Taipei, Taiwan
🇨🇳Taipei Municipal Wanfang Hospital, Taipei, Taiwan
Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
- Conditions
- ESRDHyperphosphatemiaEnd Stage Renal Disease
- Interventions
- First Posted Date
- 2019-06-13
- Last Posted Date
- 2021-03-10
- Lead Sponsor
- Panion & BF Biotech Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT03984760
- Locations
- 🇨🇳
Baotou Central Hospital, Baotou, China
🇨🇳The General Hospital of the People's Liberation Army (PLAGH), Beijing, China
🇨🇳The Second Hospital of Jilin University, Changchun, China
Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
- Conditions
- Kidney Failure, ChronicEnd-stage Renal DiseaseHyperphosphatemiaPhosphorus Metabolism Disorders
- Interventions
- First Posted Date
- 2017-08-22
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Panion & BF Biotech Inc.
- Target Recruit Count
- 202
- Registration Number
- NCT03256838
- Locations
- 🇨🇳
Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
🇨🇳Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang-Gung Memorial Hospital, Kaohsiung, Taiwan
🇨🇳Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease
- Conditions
- HyperphosphatemiaEnd Stage Renal DiseaseESRD
- Interventions
- First Posted Date
- 2012-01-04
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Panion & BF Biotech Inc.
- Target Recruit Count
- 183
- Registration Number
- NCT01503736
- Locations
- 🇨🇳
Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang-Gung Memorial Hospital, Kaohsiung, Taiwan
🇨🇳Division of Nephrology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan
🇨🇳Division of Nephrology, Department of Internal Medicine, Far East Memorial Hospital, New Taipei City, Taiwan